Menopause biotech startup exits stealth with $500M Series B
Resolves: A Series B funding round of at least $500 million is announced for a menopause-focused biotech startup by 2026-12-31, with disclosed lead investor(s).
user-generated· adoption
Menopause biotech startup exits stealth with $500M Series B
Market overview
At least one menopause-focused biotech startup will secure a $500 million Series B funding round before 2026-12-31, signaling strong institutional confidence. The round will be led by a top-tier venture capital firm with prior exits in women’s health.
adoption prediction market
- Implied probability (Yes)
- 68%
- Closes
- 2026-12-31
About this prediction
Resolution criteria
A Series B funding round of at least $500 million is announced for a menopause-focused biotech startup by 2026-12-31, with disclosed lead investor(s).
Source: user-generated
More adoption markets
- Daily active crypto users surpass 100 million by mid-2026 — 60% Yes
- Kalshi’s market share in crypto derivatives surpasses 5% by Q4 2027 — 55% Yes
- Kalshi's crypto perpetual futures launch by 2026-Q4 — 75% Yes
- Family offices double down on crypto-adjacent mining firms within 6 months — 72% Yes
- Nigeria's crypto transaction volume exceeds $5B in 2026 — 80% Yes
- AI and crypto groups increase political ad spending in 2026 midterms — 80% Yes
- Crypto and AI groups double political ad spending by 2027 — 75% Yes
- Crypto billionaire Harborne will increase donations to Farage by 20% by Mar 2027 — 60% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…